President to inaugurate indigenous cancer therapy at IIT Bombay

Daily Current Affairs / President to inaugurate indigenous cancer therapy at IIT Bombay

Change Language English Hindi

Category : National Published on: April 05 2024

Share on facebook

This development brings hope to Indian patients, offering the therapy at a significantly reduced cost of ₹40 lakh, in contrast to the exorbitant ₹5 crore expense in the US, rendering it inaccessible to many.
The CAR-T Cell Therapy (used to treat cancer patients) has been developed in India by IIT Bombay-incubated Company Immunoadoptive Cell Therapy (ImmunoACT).
CAR T-Cell therapy, a live drug, is a personalised treatment. Unlike chemotherapy, which must be administered periodically to combat the disease, CAR T-Cell therapy is patient-specific.

Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....
Weekly Current Affairs (15th December to 21st December 2024)
Read More....

President to inaugurate indigenous cancer therapy at IIT Bombay